Mass manufacturing of COVID-19 vaccine to start in India as soon as scientists give nod: PM


New Delhi, August 15

Prime Minister Narendra Modi on Saturday stated mass manufacturing of a vaccine for COVID-19 will start in India as soon as scientists give their nod and a roadmap was prepared to make sure it reaches everybody within the nation within the shortest doable time.

Addressing the nation from the ramparts of the Red Fort on India’s 74th Independence Day, Modi stated three vaccine candidates have been in numerous levels of trials within the nation, including the expertise of our scientists is like that of ‘rishi munis’.

He stated every time there was speak of COVID-19, the query that got here to everybody’s thoughts was that when would a vaccine be prepared.

“I want to tell people that the talent of our scientists is like that of ‘rishi munis’ and they are working very hard in laboratories. Three vaccines are in various stages of testing. When scientists will give us the green signal, there will be produced on a mass scale and all preparations have been made for it,” Modi stated.

A roadmap had been ready to make sure that the vaccine reaches everybody within the nation within the shortest doable time with mass manufacturing, he stated.

Three vaccine candidates have been in numerous levels of human medical trials in India.

The phase-1 and a pair of human medical trials of two of them, developed indigenously by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR), and Zydus Cadila Limited, are at present underway.

The Serum Institute of India has been permitted for conducting Phase 2 and three human medical trials of the third vaccine candidate developed by the Oxford University. The Pune-based institute has partnered with AstraZeneca for manufacturing the vaccine. PTI



Be the first to comment on "Mass manufacturing of COVID-19 vaccine to start in India as soon as scientists give nod: PM"

Leave a comment

Your email address will not be published.


*


%d bloggers like this: